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1. Introduction  
Acute pulmonary embolism (PE) is a common and potentially fatal disease (Goldhaber et 
al., 1999). The most frequent cause of death within 30 days is right ventricular (RV) failure 
(Goldhaber & Elliott, 2003). Rapid risk stratification is paramount for identifying high-risk 
patients and for helping to select the appropriate treatment strategy. According to European 
guidelines (Torbicki et al., 2008), high-risk PE (formerly ‘massive’ PE) implies the presence 
of shock or hemodynamic instability (mortality >15%) (Goldhaber et al., 1999). Non high-
risk PE can be further stratified by the presence of markers of RV dysfunction and/or 
myocardial injury as intermediate- and low-risk PE. Intermediate-risk PE (formerly ‘sub-
massive’ PE) is diagnosed by the presence of at least one marker of RV dysfunction or 
myocardial injury. Low-risk PE (formerly ‘non-massive’ PE) is diagnosed when RV 
dysfunction markers are negative (mortality <1%). Reperfusion therapy, including 
thrombolysis or surgical embolectomy, is indicated for patients with high-risk PE. However, 
the risks and benefits of reperfusion therapy for patients with intermediate risk PE are less 
clear. Based on pathophysiological knowledge of the impact of RV dysfunction on acute PE, 
risk stratification is based on imaging modalities for the visualization of RV dysfunction. 
Therefore, echocardiographic assessment of RV dysfunction in acute PE may predict early 
mortality, and may guide decisions regarding reperfusion therapy (Grifoni et al., 2000; 
Kucher et al., 2005). Echocardiography, however, is time-consuming, operator-dependent, and 
not always available in an emergency situation, and echocardiographic criteria for assessing 
RV have not yet been determined. The development of narrow collimation, multi–detector 
row computed tomography (CT) imaging, and modern workstations for image postprocessing 
and analysis have made CT pulmonary angiography the modality of choice for the assessment 
of patients with pulmonary emboli (Ghaye et al., 2006; Schoepf & Costello, 2004). At times, CT 
is more rapidly accessible in emergency settings, and is more widely available than 
echocardiography. CT enables the direct visualization of emboli and provides information 
about cardiac morphology. CT findings, including RV enlargement, the ratio of RV diameter to 
the diameter of the left ventricle (LV) (RV/LV ratio), interventricular septal bowing, and 
pulmonary vascular obstruction score, have been associated with early mortality and clinical 
outcomes (Araoz et al., 2003; Collomb et al., 2003; Coutance et al., 2011; Ghuysen et al., 2005; 
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Jimenez et al., 2010; Lu et al., 2009; Qanadli et al., 2001; Sanchez et al., 2008; Schoepf & Costello, 
2004; van der Meer et al., 2005; Wu et al., 2004).  
This chapter will focus on recent studies comparing CT and echocardiographic findings of 
RV dysfunction. The data obtained in these trials provide the background for emerging risk 
stratification algorithms, which we hope will lead to the use of chest CT as an alternative to 
echocardiography in the successful identification of RV dysfunction. 
2. Echocardiographic assessment of right ventricular dysfunction 
Transthoracic echocardiography is a noninvasive tool that can be easily utilized at the 
bedside, even in hemodynamically compromised patients. It can help diagnose conditions 
that mimic acute PE but are treated differently, such as acute myocardial infarction, aortic 
dissection, and pericardial tamponade. Although echocardiography is not recommended for 
the diagnosis of PE, it can detect or exclude RV dysfunction. Moreover, echocardiography is 
an important tool for risk stratification in patients with PE because RV dysfunction on an 
echocardiogram is a powerful and independent predictor of mortality (Ribeiro et al., 1997; 
Torbicki et al., 2003). Echocardiographic findings suggesting RV dysfunction have been 
reported to occur in at least 25% of patients with PE (Kreit, 2004). A meta-analysis found 
that patients with echocardiographic signs of RV dysfunction were at greater than two-fold 
higher risk of PE-related mortality than patients without signs of RV dysfunction (ten Wolde 
et al., 2004). Importantly, patients with normal echocardiographic findings had excellent 
outcomes, with in-hospital PE-related mortality rates <1% in most of the reported series. A 
recent systemic review (Fremont et al., 2008) identified five studies that evaluated the 
prognostic role of echocardiography in diagnosing RV dysfunction. The unadjusted relative 
risk of RV dysfunction for predicting death was 2.5 (95% CI 1.2-5.5).  
Echocardiography, however, has limitations, including restricted availability and relatively 
high cost. Moreover, in some patients, including those with chronic obstructive pulmonary 
disease or morbid obesity, it is difficult to adequately image the RV free wall with a 
transthoracic approach. More importantly, the lack of a clear echocardiographic definition of 
RV dysfunction is problematic (ten Wolde et al., 2004). A meta-analysis of eight studies that 
compared the impact of RV dysfunction measured by echocardiography and CT found that 
the presence of echocardiographically determined RV dysfunction in patients with sub-
massive PE was associated with increased short-term mortality (OR 2.36, 95% CI: 1.3-43), but 
that corresponding pooled negative and positive likelihood ratios independent of death 
rates were unsatisfactory for clinical usefulness in risk stratification (Coutance et al., 2011). 
Unfortunately, the echocardiographic criteria of RV dysfunction differ among published 
studies and have included RV dilatation, hypokinesis, increased RV/LV diameter ratio and 
increased velocity of the tricuspid regurgitation jet. Thus, since there is no universal 
echocardiographic definition of RV dysfunction, only a completely normal result should be 
considered as defining low-risk PE. This is particularly important because, in some of trials, 
echocardiographic signs of RV pressure overload alone (such as increased tricuspid 
insufficiency peak gradient and decreased acceleration time of RV ejection) were considered 
sufficient to classify a patient as having RV dysfunction.  
2.1 Echocardiographic findings of right ventricular dysfunction 
RV dysfunction is diagnosed by the presence of RV dilatation, defined as a RV/LV end-
diastolic dimension ratio >0.6 on a parasternal long-axis view or >0.9 on a four-chamber 
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view (Fig. 1); as RV systolic free wall hypokinesis (McConnell sign); or as systolic 
pulmonary arterial hypertension, defined as a tricuspid regurgitant velocity >2.6 m/s 
(Goldhaber, 2002). Indirect signs of RV pressure overload include a flattened 
interventricular septum, paradoxical systolic motion of the interventricular septum toward 
the LV, and a dilated inferior vena cava with reduced respiratory variability (Table 1).  
Signs of RV dysfunction have been found in 40-70% of patients with PE, and numerous 
studies have demonstrated that echocardiography is a useful tool for estimating the 
prognosis of normotensive patients with acute PE (Goldhaber et al., 1999; Ribeiro et al., 1997; 
Grifoni et al., 2001). A recent meta-analysis found that echocardiographic evidence of RV 
dysfunction was associated with a significantly elevated risk of death during the acute 
phase of PE (OR, 2.5; 95% CI, 1.2-5.5%) (Sanchez et al., 2008). However, since large 
populations of patients with signs of RV dysfunction have low mortality rates, 
echocardiographic detection of RV dysfunction alone does not justify more aggressive 
treatment strategies (Goldhaber et al., 1999; Konstantinides, 2008). More importantly, 
definitions of RV dysfunction differed greatly among these studies, and patients with 
chronic obstructive pulmonary disease were not excluded (Jimenez et al., 2007). In addition, 
it is difficult to differentiate chronic from acute RV overload based on standardized criteria 
(e.g. RV free wall thickness > 6 mm or tricuspid valve regurgitation jet velocity > 2.6 m/sec). 
2.1.1 Echocardiographic RV/LV ratio  
A retrospective study of 950 patients showed that the echocardiographic RV/LV ratio was 
prognostic in the evaluation of PE, with a critical cutoff for prediction of in-hospital 
mortality of 0.9 (Fremont et al., 2008). Echocardiograms were electrocardiogram (ECG)-
gated to allow end-diastolic diameter measurement on the R wave. The minor axes of the 
RV and LV were measured in apical 4-chamber views from the septum to the lateral wall 
endothelium at their widest point just above the mitral valve and tricuspid valve annulus. 
The prognostic value of this easily measurable echocardiographic parameter was 
independent of patient history and clinical data. Multivariate analysis showed that the 
independent predictors of in-hospital mortality included systolic BP < 90 mm Hg (odds ratio 
[OR], 10.73; p < 0.0001), history of left heart failure (OR, 8.99; p < 0.0001), and RV/LV ratio > 
0.9 (OR, 2.66; p < 0.01). 
2.1.2 Echocardiographic RV hypokinesis  
Moderate or severe RV free-wall hypokinesis may be accompanied by relatively normal 
contraction and “sparing” of the RV apex, a phenomenon called the McConnell sign 
(McConnell et al., 1996). In patients with PE, the McConnell sign had a sensitivity of 77%, a 
specificity of 94%, a positive predictive value of 71%, and a negative predictive value of 
96%. This sign appeared useful in distinguishing between RV dysfunction due to PE and 
dysfunction due to other conditions, such as primary pulmonary hypertension. For patients 
with RV hypokinesis due to acute PE, the excursion diminished markedly when measured 
in the middle of the RV free wall. However, the excursion improved progressively when 
segments closer to the apex were measured. This pattern of regional RV dysfunction 
appeared highly specific for acute PE; in patients with RV dysfunction due to primary 
pulmonary hypertension, RV hypokinesis was not improved when apical segments were 
assessed. 
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RV: right ventricle; LV: left ventricle; Ao: aorta; LA: left atrium 
Fig. 1. Echocardiographic findings of pulmonary embolism in the parasternal long-axis (A) 
and short-axis (B) views. 
 
Abnormal Finding Description 
Right ventricular dilatation 
The ratio of the right ventricular end-diastolic area to left 
ventricular end-diastolic area exceeds the upper limit of 
normal (>0.6 on parasternal long-axis views and >0.9 on 
apical four-chamber views) 
Septal flattening and 
paradoxical septal motion 
The interventricular septum bulges toward the left ventricle 
Reduced respiratory 
variability of the dilated 
inferior vena cava 
Subcostal view, diameter >2 cm with <50% respiratory 
variability; indirect sign of increased central venous pressure 
Pulmonary artery dilation 
Main pulmonary artery >2.5 cm on parasternal short-axis 
views; indirect sign of pulmonary hypertension 
Tricuspid regurgitation jet 
velocity >2.6 m/s 
Direct evidence of pulmonary hypertension 
Right ventricular regional 
systolic wall motion 
abnormalities 
Hypokinesis of the free wall but preserved apical kinesis 
Table 1. Abnormal echocardiographic findings in patients with pulmonary embolism  
3. Computed tomography assessment of right ventricular dysfunction 
Contrast-enhanced pulmonary CT angiography is increasingly used for first-line imaging in 
patients suspected of PE. This method allows the direct visualization of emboli, as well as 
providing information regarding the status of the right heart. Several methods have been 
suggested for the quantitative assessment of RV dysfunction by CT.  
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3.1 Computed tomography findings of right ventricular dysfunction 
3.1.1 RV dilation (RV/LV ratio) 
Similar to echocardiography, contrast-enhanced CT allows assessment of the right-to-left 
ventricular ratio. RV and LV diameters are assessed on each single image at the plane of 
maximal visualization of the ventricular cavities, usually at the mitral valve plane for LV 
and the tricuspid valve level for RV, between the inner surface endocardial border of the 
free wall and the surface of the interventricular septum (Fig. 2).  
 
 
Fig. 2. Transverse contrast-enhanced CT scan showing maximum minor axis measurements 
of the right ventricle (A) and left ventricle (B). RV/LV ratio = 2 
The RV/LV minor axis ratio is widely accepted as a measure of RV dilatation on CT, 
however, the cut-off values of RV/LV ratio used for RV dysfunction vary among reports. 
Ghuysen et al suggested an RV/LV ratio >1.5 indicates a severe episode of PE (Ghuysen et 
al., 2005), Araoz et al suggested an RV/LV ratio >1 was associated with a 3.6-fold increased 
risk of admission to the intensive care unit (Araoz et al., 2003), and in another study, the 
same threshold was shown to be a significant risk factor for mortality within 3 months, with 
an RV/LV ratio ≤1.0 having a PPV of 10.1% (95% CI: 2.9%, 17.4%) and an NPV of 100% (95% 
CI: 94.3%, 100%) for an uneventful outcome (van der Meer et al., 2005). An RV/LV ratio >0.9 
on reconstructed CT four-chamber views has been associated with a poorer prognosis in 
patients with PE (Schoepf et al., 2004), with an NPV of 92.3% and a PPV of 15.6% for 30-day 
mortality, and a hazard ratio for predicting 30-day mortality of 5.17 (95% CI, 1.63 – 16.35; 
P=0.005).   
Concerns have arisen regarding whether non-gated CT may be inaccurate in measuring 
ventricular chamber size because the images are acquired in different phases of the cardiac 
cycle. However ECG-gated CT scan is not always available, and is time-consuming. Thus, a 
ECG-gated CT scan is impractical in an emergency situation. In addition, recent findings 
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have indicated that the benefits from a separate ECG-gated CT scan for the evaluation of RV 
ventricular diameter are minimal and do not justify its routine clinical use instead of the 
standard measurements of the minor axis (Lu et al., 2009). 
Although most studies have indicated that CT assessments of RV dilatation contribute to the 
risk stratification of patients with PE, two recent meta-analyses have found that CT findings 
of RV dilatation have limited prognostic importance for mortality among patients with non-
high-risk PE (Coutance et al., 2011; Sanchez et al., 2008), and that the greatest value of this 
method appears to be the identification of low-risk patients based on the lack of RV 
dilatation. These analyses suggested that measurements made on the four-chamber view are 
more reliable than traditional measurements made on the minor axis. However, most of 
these studies were of retrospective design and in small numbers of patients with generally 
undefined clinical presentations. Hence, any conclusions about the usefulness of this marker 
must be treated with some caution, although future large clinical studies and standardized 
definitions of RV dilatation will be required in this patient subset. 
3.1.2 Interventricular septal straightening/bowing  
If RV afterload suddenly increases, the interventricular septum, which normally bows 
toward the RV, may shift toward the LV because of its confinement within the pericardium. 
This phenomenon is readily visible on helical CT pulmonary angiography as straightening 
or bowing of the interventricular septum.  
Leftward bowing of the interventricular septum on CT has been related to severe PA 
obstruction (Fig. 3). This bowing was found to strongly predict admission to the intensive 
care unit for PE, but was not associated with in-hospital mortality (Araoz et al., 2003). Thus, 
this sign is likely not an indicator of outcome and is not specific for PE (van der Meer et al., 
2005). This bowing has also been observed in patients with chronic pulmonary artery 
hypertension, although, in the latter condition, the RV wall is usually thickened (>6 mm), 
whereas, in acute PE, the RV wall thickness is usually normal.  
 
 
Fig. 3. Ventricular septal bowing (arrow) into the left ventricular lumen  
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3.1.3 Obstruction index 
The PA obstruction index, or the percentage of vascular obstruction of the pulmonary 
arterial tree caused by PE, may be calculated as Σ (n × d) expressed as percentage vascular 
obstruction ([Σ (n × d)/40] × 100), where n is the value of the proximal clot site that equals 
the number of segmental branches arising distally, and d is the degree of obstruction, with 
partial obstruction scored as 1 and complete obstruction as 2. Values for n range from a 
minimum of 1 (obstruction of one segment) to a maximum of 20 (obstruction of both right 
and left pulmonary arteries) (Qanadli et al., 2001). With this scoring system, the maximum 
obstruction score is 40 (thrombus completely obstructing the pulmonary trunk), which 
corresponds to a 100% obstruction index. Using a cutoff of 60%, 83% of the patients with an 
index >60% died, whereas 98% of patients with a lower index remained alive (Wu et al., 
2004). Patients with an obstruction index ≥ 40% were found to be at an 11.2-fold (95% CI: 1.3, 
93.6) increased risk of dying from PE (van der Meer et al., 2005). However this index may 
not be practical for routine application without the aid of radiologists. 
Another obstruction index, the pulmonary embolism severity index (PESI), was developed 
to estimate 30-day mortality in patients with acute PE. This index has also been used to 
identify patients with a low mortality risk who may be suitable for outpatient management 
of acute PE (Aujesky et al., 2007). The PESI contains 11 differently weighted baseline clinical 
parameters and is relatively complicated to administer and score. A simplified version of the 
PESI (sPESI) was therefore developed for ease of application. The sPESI showed similar 
prognostic accuracy and clinical utility as the PESI, although its use made it easier to 
identify patients at low-risk of adverse outcomes (Jimenez et al., 2010) (Table 2). 
 
 
Fig. 4. Transverse contrast-enhanced chest computed tomographic scan showing pulmonary 
emboli (arrows) in both main pulmonary arteries (PAs). This patient had a PA obstruction 
index of 55% 
3.1.4 Pulmonary artery diameter measurement 
A pulmonary artery (PA) diameter greater than 30 mm indicates a PA pressure greater than 
20 mmHg (Kuriyama et al., 1984). Moreover, the diameter of the central PA has been 
significantly correlated with the severity of PE (Collomb et al., 2003). In other studies, 
however, the diameter of the main PA and the ratio of the diameters of the main PA and the  
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PESI a sPESI b  
 Age > 80 y  Age in years  1  
 Male sex  +10   
 History of cancer  +30  1  
 History of heart failure  +10  
1 c  
 History of chronic lung disease  +10  
 Pulse ≥110 beats/min  +20  1  
 Systolic blood pressure <100 mmHg  +30  1  
 Respiratory rate ≥30 breaths/min  +20   
 Temperature <36°C  +20   
 Altered mental status  +60   
 SaO2 < 90%  +20  1  
a The total point score for each patient is calculated as the sum the patient’s age in years and the points 
for each predictor when present. 
Scores corresponding to risk classes include: 65 or less, class I; 66 to 85, class II; 86 to 105, class III; 106 to 
125, class IV; and more than 125, class V. Patients in risk classes I and II are defined as being at low risk. 
bThe total point score for each patient is calculated as the sum of the points. Scores correspond to the 
following risk classes: 0, low risk; 1 or more, high risk. 
c The variables were combined into a single category of chronic cardiopulmonary disease. 
Table 2. Original and simplified pulmonary embolism severity index (PESI) 
aorta were not indicators of mortality or severity of acute PE (Araoz et al., 2003; van der 
Meer et al., 2005).  
3.1.5 Saddle pulmonary embolism  
Saddle PE is defined as a visible thromboembolus stradding the bifurcation of the main PA 
(Fig. 5). Saddle PE occurs at frequency of (5.2%) in all patients with PE (Pruszczyk et al., 
2003). Such proximal thrombus may be regarded unstable, large clot burden in the PA, and 
“in-transit” embolus, which can fragment spontaneously or secondary to treatment and 
obstruct multiple, distal pulmonary arteries (Pruszczyk et al., 2003).  
Debate has been going on regarding the size of the clot and prognosis. Some studies suggest 
that simple distinction of saddle versus non-saddle PE by CT findings was associated with 
death within 1 year (OR 7.4, 95% CI 1.7-31.5) and may provide a straight forward method 
for risk stratification (Yusuf et al., 2010). Whereas other studies found that saddle PE was 
not associated with mortality rate and may not necessitate aggressive medical management 
(Ryu et al., 2007; Musani, 2010). Therefore the prognosis value of saddle PE is not well 
established. 
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Fig. 5. Saddle pulmonary embolism.   
4. Dual E CT  
Physiologic changes in patients with acute PE, such as RV overload, may be more closely 
related to the extent of the pulmonary perfusion defect than to the burden of intravascular 
emboli. Several studies have reported that the extent of the pulmonary perfusion defect, as 
assessed by perfusion scintigraphy or SPECT, is an important risk factor for recurrence of 
pulmonary embolism and RV dysfunction (Wolfe et al., 1994; Palla et al., 2010). However, 
CT angiography has shown better performance than perfusion scintigraphy or SPECT in the 
initial diagnosis of pulmonary embolism, since the former has several advantages, including 
high spatial resolution, rapid scanning time and easy availability.  
Recent advances in CT technology have included dual-energy CT (DECT), using two tubes 
(dual-source CT) or a single tube with a rapid kVp switching technique. As iodine has 
unique spectral properties and X-ray absorption characteristics at higher and lower photon 
energies (e.g., 140-kVp and 80-kVp), iodine map images can be generated using DECT 
angiography (DECTA). These images may represent the regional perfusion status of lung 
parenchyma and showed good correlation with scintigraphic findings in patients with PE 
(Pontana et al., 2008; Thieme et al., 2008). Weighted-average 120-kVp equivalent CT 
angiography obtained from DECTA can be used for the direct visualization of a 
thromboembolism and for the evaluation of CT signs of RV dysfunction, similar to standard 
CT angiography. That is, information about regional lung perfusion status, as well as the 
burden of intravascular emboli and right-sided heart failure, can be evaluated by single 
scanning DECT. 
RV dysfunction is predictive of a poor prognosis in patients with acute PE. On CT 
angiography images, RV/LV diameter ratio is a reliable marker of RV dysfunction, with 
higher RV/LV diameter ratios related to poor clinical outcomes (Quiroz et al., 2004; Schoepf 
et al., 2004; van der Meer et al., 2005). Furthermore, the extent of perfusion defect on DECTA 
has been correlated with RV/LV diameter ratio (Zhang et al., 2009; Chae et al., 2010; Bauer 
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et al., 2011). A novel dual energy perfusion defect score has been proposed, in which the 
degree of lung perfusion in each segment is graded on a 3-point scale (0, normal perfusion; 
1, moderately reduced perfusion, 2, profoundly reduced or absent perfusion), with the 
perfusion defect score calculated as ∑(n∙d)/40x100, where n is the number of segments 
and d is the degree of the perfusion defect (Chae et al., 2010). The perfusion defect score has 
shown good correlation with RV/LV diameter ratio (r = 0.69, p < 0.001). In addition, the 
numbers of lobes with pulmonary perfusion defects on iodine images of DECTA correlated 
well with RV/LV diameter ratio (r = 0.66, p < 0.05), whereas the number of lobes with PE on 
CT angiography did not (p > 0.05). Quantification of the area of pulmonary perfusion defect 
on iodine images showed that an pulmonary perfusion defect over 215.4 ml or a relative 
volume over 9.9% was related to an RV/LV diameter ratio > 1 (Bauer et al., 2011). These 
results therefore indicate that pulmonary perfusion defect size may be a surrogate marker 
for RV dysfunction (Fig. 6, Fig. 7). Readmission and death due to PE were observed only in 
patients with a relative perfusion defect size >5% of total lung volume, but not in any 
patient with a relative perfusion defect < 5% (Bauer, Frellesen et al. 2011). Patients with a 
relative perfusion defect >5% also showed lower median survival with increased relative 
hazard ratio for death than those with a relative perfusion defect <5%. These results indicate 
that pulmonary perfusion defect size may be prognostic in patients with PE. 
The status of the pulmonary microvasculature is important in evaluating disease severity 
and prognosis in patients with PE. Although ventilation/perfusion scintigraphy was used to 
assess the pulmonary nomenclature, multi-detector CT angiography has replaced 
scintigraphy in the evaluation of these patients, since CT has higher spatial resolution and 
shorter acquisition time. Recently developed advanced CT techniques, including DECT, 
permits the evaluation of pulmonary perfusion status without significant additional 
radiation dose. Therefore, DECTA may become a leading imaging tool, both for detecting 
emboli and for risk stratification regarding of regional pulmonary perfusion status in 
patients with PE. 
5. The role of chest computed tomography as an alternative to 
echocardiography 
Retrospective studies have shown that multidetector chest CT and echocardiography yield 
similar prognostic data (Sanchez et al., 2008). While CT provides information on RV 
dilatation only, echocardiography also provides some information on contractility, e.g., 
septal or RV hypo- or dyskinesia. However, echocardiography is not always available in 
emergency settings and has limitations, including poor RV image quality and lack of a 
universal definition of RV dysfunction. Indeed, this method has limited sensitivity and 
negative findings on echocardiography do not exclude a diagnosis of PE (Miniati et al., 2001). 
In contrast, CT pulmonary angiography allows direct visualization of clots, as well as 
providing information on the status of the right heart and other adjacent organs. This tool is 
available around the clock at most institutions and has become the first-line test for patients 
suspected of having PE. PE may be diagnosed and its risk stratified at the same time. Of 
course, CT has several limitations, including an inability to assess RV function in real time and 
the lack of universally accepted criteria. Confirmation of these findings in further, prospective 
studies may make multidetector-row chest CT a reasonable alternative to echocardiography 
for diagnosing RV dysfunction. Imaging techniques are constantly being improved in the 
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diagnostic workup of patients with suspected PE. Thus, CT has the potential to become the 














Fig. 6. Pulmonary embolism without right ventricular dysfunction. (a) Dual-energy CT 
angiography (DECTA) shows filling defect in segmental branches of pulmonary arteries  
in right lower lobe. (b) DECTA shows normal ranged diameters of ventricles 
(RV/LV ratio < 1). (c & d) Lung iodine images show wedge shaped pulmonary perfusion 
defect in right lower lobe lateral basal segment where emboli completely occludes 
pulmonary artery. However, the posterior basal segment of right lower lobe shows normal 
perfusion status, because emboli partly occlude corresponding pulmonary artery. The 
relative volume of pulmonary perfusion defect was 8.3% and perfusion defect score was 10. 
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(a)  (b)  
(c)   (d)  
Fig. 7. Pulmonary embolism with right ventricular dysfunction. (a) Dual-energy CT 
angiography (DECTA) shows filling defect in right main pulmonary artery. (b) DECTA 
shows enlarged right ventricle (RV/LV ratio > 1). (c & d) Lung iodine images show 
perfusion defect in right lung except superior segment and posterior basal segment of right 
lower lobe. Multifocal wedge shaped perfusion defect in also noted in subpleural portion of 
left lung. The relative volume of pulmonary perfusion defect was 47.8% and perfusion 
defect score was 52.5. 
6. Conclusion 
This chapter focused on the prognostic value of RV dysfunction as measured by chest CT in 
patients with hemodynamically stable PE. Although echocardiographic assessment of RV 
dysfunction is a generally accepted imaging modality, the lack of a clear echocardiographic 
definition of RV dysfunction, and the poor RV images, reduces its diagnostic capabilities. 
RV dysfunction assessed by CT, including RV enlargement, RV/LV ratio, interventricular 
septal bowing, pulmonary obstruction score, and pulmonary perfusion defect have been 
associated with poor patient outcomes. Risk stratification of patients with stable PE based 
on chest CT findings may comparable in results to echocardiography and may be useful.   
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